(Q34242523)

English

Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

chemoradiotherapy

0 references

cholangiocarcinoma

0 references

0 references

Markus Büchler

6

object named as

Büchler MW

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Habermehl D

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lindel K

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Rieken S

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Haase K

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Goeppert B

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Schirmacher P

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Welzel T

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Debus J

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Combs SE

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

13 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

188

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

795-801

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Management Strategies in Resection for Hilar Cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Changing strategies in diagnosis and management of hilar cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Limitations of conventional doses of chemoradiation for unresectable biliary cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Role of radiation after operative palliation in cancer of the proximal bile ducts

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Postoperative chemoradiotherapy for extrahepatic bile duct cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Volumetric modulated arc therapy for advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

kV cone-beam CT-based IGRT: a clinical review.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Stereotactic radiotherapy in the liver hilum. Basis for future studies

1 reference

https://api.crossref.org/works/10.1007%2FS00066-012-0099-Y

21 January 2018

Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic fractionated radiotherapy for Klatskin tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic body radiotherapy for unresectable cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22526232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-012-0099-Y

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34242523&oldid=2196411014"